Gibault et al. indicated that Verteporfin (VP) remarkably inhibits the luciferase activity of TEAD and decreases YAP/TAZ expression across MDA-MB-231 cell lines in breast cancer. This evidence concerns the gene YAP1 and breast carcinoma.